Helixgate

Helixgate

Uncategorized

Mass General Brigham says it is saving more lives. Some doctors aren’t so sure.

BOSTON — In a meeting for Mass General Brigham doctors in November 2024, Dr. Giles Boland, president of Brigham and Women’s Hospital, laid out the vision for becoming the best in the country. Thanks to a corporate merging of its hospitals, he said, the system was well on its way, making progress on delivering the best outcomes possible for patients, including its most important job — keeping people alive.

Boland specifically pointed to MGB’s strides on a metric called observed-to-expected mortality, which compares how many people died while admitted to the hospital, versus how many were projected to die, given their levels of illness.

Read the rest…

Read More

Published

on

BOSTON — In a meeting for Mass General Brigham doctors in November 2024, Dr. Giles Boland, president of Brigham and Women’s Hospital, laid out the vision for becoming the best in the country. Thanks to a corporate merging of its hospitals, he said, the system was well on its way, making progress on delivering the best outcomes possible for patients, including its most important job — keeping people alive.

Boland specifically pointed to MGB’s strides on a metric called observed-to-expected mortality, which compares how many people died while admitted to the hospital, versus how many were projected to die, given their levels of illness.

Read the rest…

Read More

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Uncategorized

Amgen shores up Tavneos’ FDA defense with Duke data analysis

Amgen shores up Tavneos’ FDA defense with Duke data analysis

Published

on

After the FDA flagged patient deaths linked to Amgen’s rare disease drug Tavneos and called for its voluntary removal, the pharma recruited an independent data analysis from Duke researchers to help build the case for the drug’s continued market approval.​ ​Read More

Continue Reading

Uncategorized

Chile offers new data on food warning label efficacy

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here.

So much news today that I didn’t have space to write an item about hot tubs as a breeding ground for Legionnaires’ disease. Here’s the CDC report, if you’re curious.

Read the rest…

Read More

Published

on

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here.

So much news today that I didn’t have space to write an item about hot tubs as a breeding ground for Legionnaires’ disease. Here’s the CDC report, if you’re curious.

Read the rest…

Read More

Continue Reading

Uncategorized

Novartis’ $12B Avidity buy pays dividends with Phase 1/2 muscular dystrophy win

Published

on

The RNA-based medicine is one of a handful of antibody-oligonucleotide conjugates that Novartis acquired last October when it took over neuromuscular-focused Avidity Biosciences.

Continue Reading
Advertisement

Trending